A compelling trend emerged in our ortho industry: companies are staying private far longer than they used to.
IPOs have been rare in recent years in Ortho. Additionally, the last five Ortho companies to go public haven't fared well from their IPO price (as of mid-June 2025).
May 2023 – Monogram Orthopaedics (80% drop in stock price, $13.50 to $2.66)
October 2021 – Bone Biologics (99+% drop in stock price, $1099.20 to $4.81)
April 2021 – Treace Medical Concepts (77% drop in stock price, $25.53 to $5.63)
February 2021 – Bioventus (61% drop in stock price, $17.22 to $6.62)
October 2020 – Par...
